Ionis Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2008 | — | — | $224.0M |
| FY2009 | $355.1M | $657.2M | $105.3M |
| FY2010 | $305.9M | $550.5M | $70.1M |
| FY2011 | $313.5M | $484.9M | $65.5M |
| FY2012 | $362.9M | $545.7M | $124.5M |
| FY2013 | $468.8M | $847.2M | $160.0M |
| FY2014 | $698.0M | $955.8M | $143.0M |
| FY2015 | $747.1M | $947.9M | $128.8M |
| FY2016 | $812.9M | $912.5M | $84.7M |
| FY2017 | $957.5M | $1.32B | $129.6M |
| FY2018 | $1.48B | $2.67B | $278.8M |
| FY2019 | $1.55B | $3.23B | $683.3M |
| FY2020 | $1.65B | $2.39B | $397.7M |
| FY2021 | $1.84B | $2.61B | $869.2M |
| FY2022 | $1.96B | $2.53B | $276.5M |
| FY2023 | $2.60B | $2.99B | $399.3M |
| FY2024 | $2.42B | $3.00B | $242.1M |
| FY2025 | $3.03B | $3.52B | $372.3M |